Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 245 Carcinoma, Non-Small-Cell Lung 226 Prostatic Neoplasms 115 Neoplasms 106 Multiple Myeloma 91 Neoplasm Metastasis 77 Colorectal Neoplasms 73 Parkinson Disease 4, Autosomal Dominant Lewy Body 69 Lung Neoplasms 67 Ovarian Neoplasms 62 Leukemia, Myeloid, Acute 50 Carcinoma, Hepatocellular 48 Melanoma 46 Leukemia, Lymphocytic, Chronic, B-Cell 44 Carcinoma, Renal Cell 43 Stomach Neoplasms 42 Urinary Bladder Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 41 Triple Negative Breast Neoplasms 40 Brain Neoplasms 40 Recurrence 39 Myasthenia Gravis 38 Small Cell Lung Carcinoma 36 Lymphoma, Follicular 35 Nasopharyngeal Carcinoma 34 Head and Neck Neoplasms 34 Pancreatic Neoplasms 32 Rectal Neoplasms 30 Lymphoma, Large B-Cell, Diffuse 30 Colonic Neoplasms 29

Interventions

Pregabalin 1 Capsaicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Breast Cancer Patient × 1 year × Clear all

NCT03794388 2026-05-05

CAPTRANE

Institut Cancerologie de l'Ouest

Phase 3 Completed

140 enrolled 6 charts

Breast Cancer Patient

Data powered by HemOnc (CC BY 4.0) Colophon ⚡